What is Diaceutics PLC (DXRX.L)?

Diaceutics PLC (DXRX.L) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

Diaceutics PLC (DXRX.L)

Stock analysis · LSE · Healthcare · Medical - Healthcare Information Services

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.88

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Diaceutics PLC (DXRX.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Sep 22, 2026

EPS $-0.03 vs est. $-0.03

Missed by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Diaceutics PLC

Diaceutics PLC, established in 2005 and headquartered in Belfast, UK, is a company dedicated to accelerating the commercialization of diagnostic solutions. It offers global pharmaceutical companies comprehensive data, advanced analytics, and implementation support. Central to its operations is the DXRX platform. This platform features DXRX data solutions, providing access to extensive diagnostic testing data pipelines from a broad network of laboratories, including real-time DXRX signal alerts, lab and physician mapping, and a testing dashboard. The DXRX platform also hosts a marketplace where laboratories, pharmaceutical firms, and diagnostic companies can connect to collaborate on precision medicine diagnostics. Diaceutics further provides DXRX Patient Journey, a tool for pharmaceutical clients to conduct detailed longitudinal analyses of individual patient biomarker testing paths, helping identify opportunities for earlier intervention and treatment. DXRX Lab Benchmarking allows laboratories to sharpen their competitive edge by comparing their key criteria against industry counterparts, encompassing metrics such as disease focus, testing methodologies, market share, turnaround…